NYSE · CNC

Centene Corporation

$64.08 +$0.67 (+1.06%) 1D After hours

Key Metrics

$31.31B
Market cap
P/E · TTM
$198.10B
Revenue · TTM
−$6.44B
Net income
EPS · TTM $-12.94
Dividend yield
Free cash flow $7.11B
Beta · 1Y 0.34
EBITDA · TTM −$5.79B
Gross margin 7.4%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 28
    The stock moved +14.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 28
  • Mar 30
    From its Mar 4 high, the share price fell 29%.

    Peak close $44.99 on Mar 4; trough close $31.80 on Mar 30. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -29%
  • Mar 10
    The stock moved -16.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 10

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$31.31B
Enterprise value$7.34B
Shares outstanding493.8M
52-wk range$25.08 – $69.36
Avg volume · 20D4.9M
Net cash $23.97B
Book value / share$43.01
IndustryHospital & Medical Service Plans
ExchangeNYSE
About Centene Corporation
IPO dateDec 13, 2001
Employees61100

Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.16
P/FCF4.40
EV/EBITDA
EV/Sales0.04
Graham №

Profitability

Gross 7.4%
Operating -3.2%
Net -3.3%
FCF 3.6%
ROE / ROIC -26.9% · -45.9%

Financial Health

Current ratio1.12
Quick ratio
Debt / equity0.76
Debt / EBITDA -2.83
Net cash $23.97B
Working capital$4.94B

Cash Flow · TTM

Operating CF $7.94B
Capex −$832.00M
Free cash flow $7.11B
Buybacks $463.00M
Dividends paid
Shareholder yield 1.5%

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

2.7
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings